链霉菌磷酸泛酰巯基乙胺基转移酶对载体蛋白的底物选择性的研究进展

磷酸泛酰巯基乙胺基转移酶(PPTase)催化脂肪酸合酶(FAS)、聚酮合酶(PKS)和非核糖体肽合成酶(NRPS)中载体蛋白从脱辅基形态转化为全辅基形态,对脂肪酸、PKS产物和NRPS产物的生物合成起着不可或缺的作用。本文介绍并总结了链霉菌PPTase对载体蛋白底物选择性的最新研究进展:Ⅲ型PPTase特异性催化同一个多肽链中ACP的辅基化;Ⅱ型PPTase倾向于催化Ⅰ型PKS中ACP和NRPS中PCP的辅基化;Ⅰ型PPTase倾向于催化Ⅱ型PKS中ACP和Ⅱ型FAS中ACP的辅基化;编码基因位于基因簇内的Ⅰ型/Ⅱ型PPTase倾向于催化编码基因位于同基因簇内的PKS/NRPS中ACP/PCP的辅基化;这些研究结果为阐明并改造链霉菌辅基化网络以提高特定次级代谢产物的产量提供了参考和借鉴。     

非核糖体肽的生物合成研究进展

非核糖体肽(nonribosomal peptide, NRP)是由多种微生物通过非核糖体肽合成酶(nonribosomal peptide synthetase, NRPS)等催化合成的一类小分子多肽类次级代谢产物,具有抗菌、抗肿瘤、免疫抑制等多种生物活性,是一类重要的微生物药物,具有很高的临床应用价值。从目前已发现的小分子多肽类天然药物出发,综述了该类物质的生物功能、合成组装机制以及近年来在工程改造方面的进展,并提出了未来研究发展方向,对进一步通过组合生物合成等方式高效合成更多种类的小分子多肽类活性物质具有借鉴意义。     

非核糖体肽合成酶催化模块的重构与多肽合成

天然次级代谢产物是重要的药物来源,非核糖体肽(non-ribosomal peptide, NRP)是自然界中广泛存在的次级代谢产物,其多样的化学结构使其具有多种生物活性,如抗炎、抗肿瘤、抗病毒等。基于非核糖体多肽合成酶(nonribosomal peptide synthetases, NRPS)模块化线性合成多肽的原理对其催化模块进行改造、重组,定向设计多肽的生物合成途径以获得目的多肽已成为一个研究热点。然而杂合NRPS存在催化模块无法加载目标氨基酸或多肽合成效率显著降低等诸多问题,限制了其应用。近年来,NRPS腺苷酰化域(adenylation domain, A域)及缩合结构域(condensation domain, C域)的底物选择性、NRPS亚基间对接域(docking domain, DD)和模块间连接区(linker)的研究已取得较大突破。从C域对底物的选择性及以不同融合边界进行催化单元替换两方面进行综述,介绍NRPS催化模块重构的研究进展,并概述了各替换方案的优点与局限性。     

非核糖体肽合成酶基因腺苷酰化结构域序列克隆及分析

微生物许多非核糖体肽类次生代谢产物主要是由非核糖体肽合成酶(NRPS)催化合成。参考Gontang发布的非核糖体肽合成酶(NRPS)通用引物设计扩增NRPS腺苷酰化结构域基因序列的特异引物,从海洋链霉菌L1的基因组DNA中扩增获得一个715 bp的NRPS基因序列。测序结果及比对分析表明该片段属于NRPS腺苷酰化结构域部分序列。对其拟翻译的氨基酸序列组成成分、理化性质进行分析,显示其包含AFD class I超基因家族核心结合区,为NRPS腺苷酰化结构域(A结构域)所在区域。对氨基酸序列的二级结构预测和三级结构模拟,发现与数据库中肠菌素合酶F组分的结构相似。为后续研究A结构域的特异性及完整NRPS基因簇克隆提供了参考。     

非核糖体肽合成酶工程改造研究进展

非核糖体肽合成酶合成的非核糖体肽类天然产物具有丰富的结构和多样的功能,在医药、农业、工业等领域具有广泛的应用潜力.利用合成生物技术工程改造非核糖体肽合成酶,在微生物细胞工厂中组合生物合成新型非核糖体肽分子顺应绿色化学的发展理念,是国内外学者关注的热点.文中归纳了3种不同的非核糖体肽合成酶工程改造策略,并对近年来相关领域...     

非核糖体肽合成酶(NRPSs)作用机理与应用的研究进展

许多微生物能利用非核糖体肽合成酶(NRPSs)合成结构复杂、种类繁多的的生物活性肽。非核糖体肽因其独特的理化特性和药理学特性已被广泛关注,极具商业开发潜力。NRPSs由多个模块组成,模块的不同空间排列顺序决定其多肽产物的氨基酸序列特异性。NRPSs以多载体巯基化模板机理进行多肽合成,其底物特异性由腺苷酰化结构域和缩合结构域共同实现。目前,人们已经利用天然的NRPSs、某些特定结构域、将已知NRPSs的模块或特定结构域进行组合甚至杂合组合而构建成的新的NRPSs来合成目的多肽。     

非核糖体肽合成酶缩合结构域基因片段克隆

从大连渤海海域筛选出1株放线菌L1,结合形态观察、生理生化实验和16S rDNA分子鉴定,确定L1属于链霉菌属球孢链霉菌(Streptomyces globisporus)。根据GenBank发布的非核糖体肽合成酶(NRPS)序列设计引物,从放线菌L1的基因组DNA中扩增获得NRPS基因片段。测序结果及比对分析表明该片段属于NRPS缩合结构域部分序列。三维建模显示其结构呈V型,包含缩合结构域核心序列,与数据库已知结构相一致,可以推断该克隆片段为NRPS缩合结构域基因片段,为后续深入研究缩合结构域特异性与相关NRPS功能提供基础。     

二酮哌嗪类化合物生物合成研究进展

二酮哌嗪类化合物(Diketopiperazines,DKPs)的特征结构是由两个氨基酸通过肽键缩合而成的环二肽(Cyclic dipeptides),稳定的六元环骨架结构使DKPs在药物化学中成为一个重要的药效团,表现出多种生物活性与药理活性,日益引起人们的极大关注。随着现代生物技术和高通量测序技术的飞速发展,人们对DKPs生物合成的分子机制与酶学机理的认识不断深入,DKPs中氨基酸缩合的分子机制主要有两种:非核糖体肽合成酶(Non-ribosomal peptide synthases,NRPSs)途径和环二肽合成酶(Cycliodipeptide synthases,CDPSs)途径。本文就近年来DKPs的生物合成相关研究进展进行了综述。     

非核糖体肽合成酶装配机制研究进展CSCD

非核糖体多肽(nonribosomal peptide,NRP)是天然生物活性产物一大类群,组成结构多样,具有多种重要的药用价值。在微生物中催化非核糖体多肽生物合成的是非核糖体肽合成酶(nonribosomal peptide synthetase,NRPS),NRPS是一类模块酶系,模块的组装在非核糖体多肽合成及其环化中起着关键作用。本文主要对非核糖体肽合成酶常规模块组装模式及3种非常规合成模式进行综述,为深入了解和应用非核糖体肽合成酶在抗生素类生物活性物质中的作用提供理论依据。     

PICKI的结构与功能研究进展

PICKI蛋白是一个从线虫到人都高度保守膜周蛋白,在多种组织中表达,尤以脑和睾丸的表达最高。在细胞内,PICKI定位于核周区和诸如神经突触的特化细胞结构中。PICKI蛋白含一个PDZ结构域和一个BAR结构域,PDZ结构域能和许多膜蛋白结合,而BAR结构域能与脂质分子（主要为磷酸肌醇）相结合,通过这种机制PICKI可调节相关蛋白的亚细胞定位和膜表达。由于各蛋白与PICKI相互作用的PDZ结合基序不同,可利用与特定蛋白结合基序相同的PDZ结合多肽竞争性地结合PDZ结构域,特异性地阻断该蛋白的作用,从而特异性地增强或减弱PICKI在某组织中的作用,为PICKI的临床应用提供了药理基础。     

Solution structure of Asl1650, an acyl carrier protein from Anabaena sp. PCC 7120 with a variant phosphopantetheinylation-site sequence

Cyanobacteria, such as Anabaena, produce a variety of bioactive natural products via polyketide synthases (PKS), nonribosomal peptide synthetases (NRPS), and hybrid peptide/polyketide pathways. The protein Asl1650, which is a member of the acyl carrier protein family from the cyanobacterium Anabaena sp. PCC 7120, is encoded in a region of the Anabaena genome that is rich in PKS and NRPS genes. To gain new insight into the physiological role of acyl carriers in Anabaena, the solution structure of Asl1650 has been solved by NMR spectroscopy. The protein adopts a twisted antiparallel four-helix bundle fold, with a variant phosphopantetheine-attachment motif positioned at the start of the second helix. Structure comparisons with proteins from other organisms suggest a likely physiological function as a discrete peptidyl carrier protein.     

Malonyl-CoA: acyl carrier protein transacylase from Helicobacter pylori: Crystal structure and its interaction with acyl carrier protein

Malonyl-CoA: acyl carrier protein transacylase (MCAT) is a critical enzyme responsible for the transfer of the malonyl moiety to holo-acyl carrier protein (ACP) forming the malonyl-ACP intermediates in the initiation step of type II fatty acid synthesis (FAS II) in bacteria. MCAT has been considered as an attractive drug target in the discovery of antibacterial agents. In this study, the crystal structure of MCAT from Helicobacter pylori (Hp) at 2.5 angstroms resolution is reported, and the interaction of HpMCAT with HpACP is extensively investigated by using computational docking, GST-pull-down, and surface plasmon resonance (SPR) technology-based assays. The crystal structure results reveal that HpMCAT has a compact folding composed of a large subdomain with a similar core as in alpha/beta hydrolases, and a similar ferredoxin-like small subdomain as in acylphosphatases. The docking result suggests two positively charged areas near the entrance of the active site of HpMCAT as the ACP-binding region. Binding assay research shows that HpMCAT demonstrates a moderately binding ability against HpACP. The solved 3D structure of HpMCAT is expected to supply useful information for the structure-based discovery of novel inhibitors against MCAT, and the quantitative study of HpMCAT interaction with HpACP is hoped to give helpful hints in the understanding of the detailed catalytic mechanisms for HpMCAT.     

Modulating the activity of the peptidyl transferase center of the ribosome

The peptidyl transferase (PT) center of the ribosome catalyzes two nucleophilic reactions, peptide bond formation between aminoacylated tRNA substrates and, together with release factor, peptide release. Structure and function of the PT center are modulated by binding of aminoacyl-tRNA or release factor, thus providing the basis for the specificity of catalysis. Another way by which the function of the PT center is controlled is signaling from the peptide exit tunnel. The SecM nascent peptide induces ribosome stalling, presumably by inhibition of peptide bond formation. Similarly, the release factor-induced hydrolytic activity of the PT center can be suppressed by the TnaC nascent peptide contained in the exit tunnel. Thus, local and long-range conformational rearrangements can lead to changes in the reaction specificity and catalytic activity of the PT center.     

Kinetics and thermodynamics of thermal denaturation in acyl carrier protein.

The denaturation of Escherichia coli acyl carrier protein (ACP) in buffers containing both monovalent and divalent cations was followed by variable-temperature NMR and differential scanning calorimetry. Both high concentrations of monovalent salts (Na+) and moderate concentrations of divalent salts (Ca2+) raise the denaturation temperature, but calorimetry indicates that a significant increase in the enthalpy of denaturation is obtained only with the addition of a divalent salt. NMR experiments in both low ionic strength monovalent buffers and low ionic strength monovalent buffers containing calcium ions show exchange between native and denatured forms to be slow on the NMR time scale. However, in high ionic strength monovalent buffers, where the temperature of denaturation is elevated as it is in the presence of Ca2+, the transition is fast on the NMR time scale. These results suggest that monovalent and divalent cations may act to stabilize ACP in different ways. Monovalent ions may nonspecifically balance the intrinsic negative charge of this protein in a way that is similar for native, denatured, and intermediate forms. Divalent cations provide stability by binding to specific sites present only in the native state.     

细菌源吡咯里西啶类生物碱的发现及生物合成研究进展

吡咯里西啶类生物碱(Pyrrolizidine Alkaloids,PAs)在高等植物中分布广泛,目前超过6 000种植物产生了 650余个PAs.源于细菌的PAs发现较少,其中Clazamycin A和Clazamycin B由Umezawa等在1979年报道.近年来在微生物基因组和合成生物学发展的驱动下,细菌源PA...     

嗜水气单胞菌非核糖体肽合成酶基因功能研究

非核糖体肽是微生物体内一类具有天然生物活性的次生代谢物,由非核糖体肽合成酶催化生成。而AHA2474和AHA2476是嗜水气单胞菌ATCC7966中两个编码非核糖体肽合成酶的基因。利用同源重组技术分别构建了AHA2474、AHA2476基因缺失株,并对其生理特性进行测定。结果表明,与野生株相比,缺失株的溶血性和胞外蛋白酶活性均显著增强,而产铁能力明显减弱;在缺铁条件下,缺失株的生长能力较弱,补充铁离子后又能恢复生长。同时在过氧化氢应激下ΔAHA2474菌株具有更大的耐受性。以上研究结果提示AHA2474和AHA2476基因可能通过影响铁离子动态平衡过程来调控该菌的生理特性,同时也表明非核糖体肽在该菌致病性方面起作用,为探究该菌的致病机制及防治策略提供理论依据。     

苹果树腐烂病菌非核糖体多肽合成酶基因VmNRPS12的功能

【目的】非核糖体多肽合成酶(NRPS)在植物病原真菌与其寄主互作过程中发挥着重要作用,明确Vm NRPS12基因在苹果树腐烂病菌致病过程中的功能,将为今后深入研究苹果树腐烂病菌NRPS作用机制提供理论依据。【方法】基于苹果树腐烂病菌全基因组数据,得到VmNRPS12基因。运用qRT-PCR技术分析VmNRPS12在侵染初期的表达水平,利用Double-joint PCR和PEG介导的原生质体转化获得该基因抗潮霉素的突变体,对突变体进行PCR检测及Southern blot验证得到敲除突变体,进一步通过重新导入该基因全长片段获得互补突变体,最后对野生型、敲除突变体和互补突变体进行菌落、产孢及致病力观察,对检测数据用SPSS软件进行差异显著性分析。【结果】定量分析显示该基因在侵染初期显著上调表达,且接种48 h后的表达量是对照的138.6倍。该基因的敲除突变体在营养生长及产孢方面与野生型菌株03-8相比无显著性差异,但致病力与野生型菌株03-8相比显著减弱,且互补突变体致病力近似恢复至野生型水平。【结论】VmNRPS12基因与苹果树腐烂病菌致病性相关。     

Purification and characterization of multiplication-stimulating activity (MSA) carrier protein

The rat liver cell line, BRL-3A, is known to produce a family of polypeptides referred to as multiplication-stimulating-activity (MSA). Serum-free conditioned medium from this cell line is a rich source for the purification of these somatomedin-like molecules. Somatomedins in serum, as well as MSA produced by BRL-3A cells in culture, exist primarily as a high molecular weight complex bound to specific carrier proteins. This study describes the purification of the MSA carrier protein (MCP) from conditioned medium using affinity chromatographic procedures. The purified carrier protein is shown to specifically bind labeled MSA and generates a complex with an apparent molecular weight of 60,000–70,000 daltons. Characterization of the carrier protein indicates that it consists of two different noncovalently linked protein chains with apparent molecular weights of 30,000 and 31,500 daltons. The availability of a pure carrier protein should provide a unique opportunity to investigate the functional significance of the carrier protein in the biological activity of the somatomedins.